Data Sheet

MenaQ7® K2: Patent Protection, Confirmed Benefits

Format: PDF file | Document type: Data Sheet | Promoted Content

This content is provided by NattoPharma – Gnosis by Lesaffre, and any views and opinions expressed do not necessarily reflect those of

MenaQ7® K2: Patent Protection, Confirmed Benefits

Vitamin K2 is the new cardio-support nutrient because clinical studies have confirmed it delivers what no other compound can: reduction in arterial stiffening.

But not all K2s have been shown to deliver this health benefit.

MenaQ7®​ was the Vitamin K2 as MK-7 used in 19+ published clinical trials confirming safety & efficacy, including the ground-breaking studies demonstrating K2 is a cardio-support nutrient. This evidence is why MenaQ7®​ is the only K2 as MK-7 patented for cardiovascular health.

Visit NattoPharma at SSE Booth C129 to discuss proven MenaQ7®​ and its robust patent portfolio.

Related resources from NattoPharma – Gnosis by Lesaffre

Show more

Supplier info centre